GlassScriptPhysician profile
Christopher J Witt
NPI 1144270406
$3,408.07
in general payments reported to CMS, 2019-2025
26 companies · $657 in 2025
The $657 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $344 · 2021: $625 · 2022: $588 · 2023: $380 · 2024: $466 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.49 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $771.04 | 2019-2025 | |
| Glaxosmithkline, LLC. | $525.02 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $352.51 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $285.63 | 2019-2024 | |
| Stryker Corporation | $247.56 | 2019-2025 | Xpress Loprofile |
| Intersect Ent, INC. | $240.27 | 2020-2022 | |
| Alk-Abello, INC | $202.91 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Phathom Pharmaceuticals, INC. | $116.63 | 2024-2025 | Voquezna |
| Kaleo, INC. | $102.23 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Aerin Medical INC. | $70.83 | 2019-2020 | |
| Medtronic, INC. | $42.35 | 2024 | Propel |
| Smith+Nephew, INC. | $37.90 | 2025 | Rf20000, Tula |
| Merck Sharp & Dohme LLC | $36.61 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $36.20 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $34.77 | 2021 | |
| Paratek Pharmaceuticals, INC. | $31.45 | 2025 | Xhance |
| Acclarent, INC | $29.57 | 2024 | Trudi Nav Cable |
| Hikma Pharmaceuticals USA | $26.53 | 2023 | Ryaltris |
| Karl Storz Endoscopy-America | $23.48 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.32 | 2022 | |
| Inspire Medical Systems, INC. | $18.16 | 2023 | Inspire |
| Vertex Pharmaceuticals Incorporated | $16.81 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $14.27 | 2025 | Neffy |
| Baudax Bio INC. | $13.86 | 2020 | |
| Olympus America INC. | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Witt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.